NEWARK, DELL, Jan. 5, 2023 (GLOBE NEWSWIRE) — The Global Surgical Retractor Market US$1.8 a billion expected to reach in 2021 4.1 USD a billion By 2032, a recent market study found Future Market Insights (FMI). According to the report’s findings, revenue from neurosurgical applications is 10.7% CAGR during the forecast period.
around it 12% Percentage of all neurological patients who die from these diseases each year, according to the World Federation of Neurology. According to WHO, neurological diseases cause an increase in disability-adjusted life years lost globally. 95 man in 2015 103 man 2030.
Surgery is the single and major treatment for neurological disorders. The increase in neurosurgical procedures and the high demand for surgical retractors manufactured specifically for these procedures are the main reasons why the neurosurgery segment dominates the surgical retractor market.
Sample request@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15931
The United States holds the largest share of the market throughout the analysis period
From 2022 to 2032, surgical retractor market is estimated to occur at a CAGR of 8.9% in the United States; 1.1 USD a billion By 2032. Four% of GDP in the 1960s 19.7% In terms of GDP in 2020, US healthcare spending has increased significantly.
Chronic Kidney Disease Affects 15% According to the American Centers for Disease Control and Prevention, the rising prevalence of chronic diseases is therefore projected to increase the need for surgical intervention. This increases the demand for surgical retractors and creates absolute dollar growth potential. $663 man.
Surgical Retractors Market: Competitive Insights
Major companies operating in the surgical retractor market include Baxter International Inc., B. Braun Melsungen AG, The Cooper Companies, Inc., Terumo Corporation, Teleflex Incorporated, Medtronic Plc., Medline Industries INC., Johnson & Johnson , NOVO NORDISK, Integra Lifesciences Holdings Corporation, HENKE-SASS WOLF, Henry Schein, Inc., Dickinson and Company, Conmed Corporation, SKLAR Surgical Instruments., Teleflex Incorporated., Olympus Corporation, Thompson Surgical, Arthrex, Inc., Microsurgical Technology, STRYKER CORPORATION, GLOBUS MEDICAL, Applied Medical Resources Corporation, Innomed, Inc., LiNA Medical ApS, Vivo Surgical Private Limited, Changzhou Haiers Medical Devices Co. Ltd.
Customization request@ https://www.futuremarketinsights.com/customization-available/rep-gb-15931
Some of the recent developments by leading providers in Surgical Retractors Market are:
- April 2021, Medtronic plc established a partnership with the company to connect the StealthStation S8 surgical navigation system with Surgical Theater’s SyncAR augmented reality (AR) technology. Through this partnership, neurosurgeons will be able to use augmented reality (AR) technology in real time to improve visualization during challenging cranial surgery.
- March 2020, A collaboration between JUNE MEDICAL and Vivo Surgical was established to create the Galaxy II LUX self-retaining ring retractor with light. A Galaxy II retractor provided by June Medical combined with a KLARO light with a dedicated clip provided by Vivo Surgical to create this gadget. It has the advantage of removing the drawbacks of using overhead lighting or personal head torches.
- May 2019, ONETRAC LX is a newly created disposable cordless surgical retractor with multi-LED light source and dual smoke evacuation channels, introduced by OBP, one of the leading manufacturers of self-contained disposable medical devices. rice field. The newly created Surgical Retractor provides the best possible smoke removal capabilities for surgeons and nurses during surgery.
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the surgical retractors market, presenting historical market data (2017-2021) and forecast statistics for 2022-2032.
The study provides a breakdown by type (handheld and self-retaining), by product type (abdominal retractor, finger retractor, nerve retractor, orthopedic retractor, rectal retractor, thoracic retractor, ribbon retractor, and other product types). Significant growth in the surgical retractors market has been revealed. , By Application Size (Neurosurgery, Wound Closure, Reconstructive Surgery, Cardiovascular, Orthopedic, Obstetrics & Gynecology (Obstetrics), and Other Applications), By End Use (Hospitals, Ambulatory Surgery Centers, and Clinics) ), five regions (North America, Latin America, Europe, Asia Pacific, Middle East and Africa).
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-15931
Key Segments Covered in Surgical Retractors Market Study
By product type:
- abdomen retractor
- finger retractor
- nerve retractor
- orthopedic retractor
- rectal retractor
- chest retractor
- ribbon retractor
- Other product types
By application size:
- wound closure
- reconstructive surgery
- Obstetrics and Gynecology (Obstetrics and Gynecology)
- Other applications
By end use:
- Ambulatory Surgery Center
buy now: https://www.futuremarketinsights.com/ask-question/rep-gb-15931
table of contents
1.1.Global market outlook
1.2. Demand Side Trends
1.4.technology roadmap analysis
1.5.Analysis and recommendations
2. Market overview
2.1. Market Scope/Taxonomy
2.2. MARKET DEFINITION/SCOPE/LIMITATIONS
3. Market Background
3.1. Market dynamics
View full report @ https://www.futuremarketinsights.com/reports/surgical-retractors-market
Explore FMI’s extensive coverage of the healthcare space.
Hermansky Pudlak Syndrome Therapeutics Market Size: The global Hermansky Pudlak Syndrome Therapeutics market will capture a market value of USD 6 billion in 2023, growing to a market size of USD 12 billion, registering a CAGR of 7.2% during the forecast period in 2023. expected to accumulate value. -2033.
Myelofibrosis (MF) Therapeutics Market Trends: The global Myelofibrosis (MF) Therapies market is expected to reach USD 749.05 million in 2023, at a CAGR of 5.5% from 2023 to 2033. Predicted.
Myotonic Dystrophy Treatment Market Growth: The global myotonic dystrophy treatment market size is expected to reach USD 874.39 million in 2023.
Isovaleric Acid Therapeutics Market Outlook: The global isovaleric acid therapies market will reach a valuation of $652.28 million in 2023 and is projected to reach $1,125.15 by 2033.
CRISPR and Cas Gene Market Forecast: A newly released CRISPR and Cas Gene market analysis report by Future Market Insights shows that the global CRISPR and Cas Gene market will stand at US$1.8 billion in 2021. The projected market growth rate from 2023 to 2033 is 30.2%, which is expected to be significantly higher than the historical growth rate.
about us :
Future Market Insights, Inc. is an ESOMAR accredited business consulting and market research firm, a member of the Greater New York Chamber of Commerce and headquartered in Delaware, USA. Winner of the Clutch Leaders Award 2022 for our high client score (4.9/5), we have worked with global companies on their business transformation journeys and helped them realize their business ambitions. Our clients are 80% of the largest Forbes 1000 companies. We serve global clients across all major and niche market segments in all major industries.
Future Market Insight Co., Ltd.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
LinkedIn | Twitter | Blog | YouTube
Sales inquiries: firstname.lastname@example.org